Efficacy of perindopril in reduction of cardiovascular events among patients with stable coronary artery disease: randomised, double-blind, placebo-controlled, multicentre trial (the EUROPA study)
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
2,150
total citations
- FWCI
- 104.56
- Percentile
- 100%
- References
- 31
Citations per year
Authors
2Topics & keywords
Topics
Keywords
- Perindopril
- Medicine
- Myocardial infarction
- Clinical endpoint
- Internal medicine
- Cardiology
- Coronary artery disease
- Placebo
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.